NCT06229587

Brief Summary

Assessment of speech and the middle ear function of patients between the age of 3 and 7 years surgically treated by ARC (Furlow z-palatoplasty with a buccinator myomucosal flap) was done. Middle ear function was assessed by clinical otoscopic examination and by tympanometry to detect the presence or absence of middle ear effusion and the need for tympanostomy tubes. Speech outcomes were assessed using perceptual speech assessment for the degree of hypernasality, compensatory misarticulation and speech intelligibility. Nasopharyngoscopic examination of the patients was done for visualization of the velopharyngeal port, allowing assessment of the pattern and grade of velopharyngeal closure during speech and the presence or absence of a velopharyngeal gap

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 1, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

27 days

First QC Date

January 1, 2024

Last Update Submit

April 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • speech assessement

    Nasopharyngoscopic examination of the cleft patients after repair with Furlow with buccinator flap allowing assessment of the grade of velopharyngeal closure during speech

    3years

Study Arms (1)

furlow with buccinator arm

EXPERIMENTAL
Procedure: furlow with buccinator flap

Interventions

Assessment of speech and the middle ear function of patients between the age of 3 and 7 years surgically treated by ARC (Furlow z-palatoplasty with a buccinator myomucosal flap) was done

furlow with buccinator arm

Eligibility Criteria

Age3 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \- Age 3 to 7 years
  • ry cleft repair by furrolow with buccal myomucosal flap
  • Non syndromic previously treated children
  • Cleft repaired by the same surgeon

You may not qualify if:

  • \- Syndromic patient
  • Cleft palate repair by any technique except furlow with buccal myomucosal flap

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hearing Institution

Giza, Egypt

Location

MeSH Terms

Conditions

Cleft Palate

Condition Hierarchy (Ancestors)

Jaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesMouth AbnormalitiesMouth DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

January 1, 2024

First Posted

January 29, 2024

Study Start

February 1, 2024

Primary Completion

February 28, 2024

Study Completion

March 1, 2024

Last Updated

April 30, 2024

Record last verified: 2024-04

Locations